Back to Awarded Treatment Trials
Awarded Trial: 01T-046
Grant ID
01T-046
Illness
Schizophrenia
Primary Drug/Intervention
Tiagabine
Primary Dosage
16 mg b.i.d.
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Woo
Sample Size
40
Duration of Study Period for Each Subject
12 months
Outcome Measurements
PANSS, working memory, volumetric MRI
Results
Grant terminated due to poor enrollment.
Publication
N/A
Link
N/A
PI Name
Tsung-Ung Woo
Degree
MD
Center
McLean Hospital
Institution
N/A
Address
Laboratory for Structural Neuroscience, 115 Mill Street
City or Town
Belmont
State or Province
MA
Zip or Postal Code
2478
Country
USA
Email Address
wilson_woo@hms.harvard.edu